Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any primary ciliary dyskinesia in which the cause of the disease is a mutation in the DNAI1 gene.
Features include always present findings: Chronic sinusitis, Atelectasis, Absent outer dynein arms, and Immotile cilia and others. 20 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 3 | Bronchiectasis, Pneumonia, Recurrent bronchitis |
Brain and nerves | 3 | Ciliary dyskinesia, Headache, Communicating hydrocephalus |
Ears | 2 | Conductive hearing impairment, Chronic otitis media |
Hormones | 1 | Male infertility |
Eyes | 1 | Abnormal cornea morphology |
DNAI1 encodes dynein axonemal intermediate chain 1 (699 aa). Component of dynein, a family of motor proteins essential for movement along microtubules. Required for structural and functional integrity of cilia. Part of the dynein complex of respiratory cilia Highest expression in Testis (53.4 TPM) and Pituitary (20.9 TPM).
Primary ciliary dyskinesia 1 is caused by mutations in the DNAI1 gene on chromosome 9.
DNAI1 is classified as a druggable target with score 0.0.
Genetic testing for DNAI1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for primary ciliary dyskinesia 1 has been reported in the published literature.
Phenotype severity distribution: 6 always present features.
1 clinical trial registered. Interventions under study include gene therapy. Research is primarily industry-sponsored.
131 publications have been identified in PubMed for primary ciliary dyskinesia 1. Research spans Review / Meta-Analysis (25%), Case Report / Case Series (24%), and Basic Science / Preclinical (21%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 30 | 25% |
Patient case studies | 29 | 24% |
Laboratory research | 25 | 21% |
Disease patterns and progression | 22 | 18% |
Testing and diagnosis research | 8 | 7% |
New treatment approaches | 4 | 3% |
Other research | 1 | 1% |
Guo C (2026). [PMID: 42260890](https://pubmed.ncbi.nlm.nih.gov/42260890/). *Medicine (Baltimore)*. [Case Report / Case Series]
Wåhlander J (2026). [PMID: 41582098](https://pubmed.ncbi.nlm.nih.gov/41582098/). *Lung*. [Basic Science / Preclinical]
Boutaud L (2026). [PMID: 40841990](https://pubmed.ncbi.nlm.nih.gov/40841990/). *Clin Genet*. [Case Report / Case Series]
Kapania EM (2026). [PMID: 28846277](https://pubmed.ncbi.nlm.nih.gov/28846277/). *Unknown Journal*. [Basic Science / Preclinical]
Kaspi E (2026). [PMID: 41827979](https://pubmed.ncbi.nlm.nih.gov/41827979/). *Diagnostics (Basel)*. [Diagnostic / Biomarker]
Schofield L (2026). [PMID: 41964363](https://pubmed.ncbi.nlm.nih.gov/41964363/). *Physiother Theory Pract*. [Epidemiology / Natural History]
Horani A (2026). [PMID: 42026914](https://pubmed.ncbi.nlm.nih.gov/42026914/). *Pediatr Pulmonol*. [Review / Meta-Analysis]
Ma R (2026). [PMID: 42216596](https://pubmed.ncbi.nlm.nih.gov/42216596/). *Br J Hosp Med (Lond)*. [Case Report / Case Series]
Thawanaphong S (2026). [PMID: 42104487](https://pubmed.ncbi.nlm.nih.gov/42104487/). *Allergy Asthma Clin Immunol*. [Epidemiology / Natural History]
Harman K (2026). [PMID: 41889169](https://pubmed.ncbi.nlm.nih.gov/41889169/). *Pediatr Pulmonol*. [Review / Meta-Analysis]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 1:01 PM UTC
Online Mendelian Inheritance in Man
European rare disease database